The Race to Salvage Glucocerebrosidase: Understanding Small‐Molecule Therapies for GBA1 ‐Associated Parkinsonism

This is the authors' abstract. We don't add key points for this paper.

Variants in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase, cause Gaucher disease and confer an increased risk for parkinsonism. Strategies using small molecules can improve the function of glucocerebrosidase in lysosomes. A clear understanding of the mechanism-of-action of these compounds will facilitate development of GBA1-modulating drugs for Parkinson's disease.